Breathlessness in a 7-Year-Old Boy - Clinical Approach

Differential Diagnosis

"The differential diagnosis for childhood asthma includes bronchiolitis, laryngotracheobronchitis (croup), pneumonia, cardiac disorders (e.g., myocarditis), and gastroesophageal reflux." - ROSEN's Emergency Medicine

History to Elicit

• Onset: Acute vs. chronic/recurrent?
• Triggers: Exercise, cold air, allergens, smoke, URIs?
• Time pattern: Nocturnal? Episodic? Continuous?
• Associated symptoms: Fever, cough (barky vs. productive), runny nose, rash, weight loss, sweating during feeds?
• Past history: Previous similar episodes? Eczema, allergic rhinitis?
• Family history: Asthma, atopy, allergies?
• Choking episode: Possibility of foreign body aspiration?

Examination

Vital Signs

Key Examination Points

• Auscultation: Wheeze (expiratory = asthma), stridor (croup/upper airway), rales (pneumonia/pulmonary edema), diminished breath sounds (severe bronchospasm, effusion, foreign body)
• Cardiac exam: Murmur, hepatomegaly (cardiac cause)
• Skin: Eczema, urticaria (atopy)
• Symmetry: Unilateral reduced air entry suggests foreign body or effusion
• Pulse oximetry: Mandatory

Investigations

• Pulse oximetry (immediate)
• Peak Expiratory Flow Rate (PEFR) if age >5 and cooperative (best of 3 attempts, standing)
• Chest X-ray: Not routine for all wheezing children. Indicated if: history of choking, focal chest signs, extreme distress, subcutaneous emphysema, or cardiac etiology suspected

• ABG: For severe bronchospasm with signs of respiratory failure. A PaCO2 ≥40 mmHg in a hypoxic child with retractions = impending respiratory failure
• CBC, CRP (if infection suspected)
• ECG/Echo (if cardiac cause considered)

Management - Likely Asthma (Most Common)

Mild Exacerbation

• Salbutamol (albuterol) SABA via MDI + spacer or nebulizer every 20 minutes for the first hour
• MDI + spacer is as effective as nebulization (per meta-analyses)
• Oral corticosteroids if: prior home SABA use, no prompt response to SABA

Moderate Exacerbation

• Repeated SABA (every 20 min x3)
• Systemic corticosteroids: Oral prednisolone 1-2 mg/kg/day (max 40-60 mg)
• Ipratropium bromide nebulized (anticholinergic, add-on)
• Oxygen to maintain SpO2 >95%

Severe/Impending Failure

• Continuous nebulized SABA
• IV/IM magnesium sulfate
• IV corticosteroids
• NIPPV (BiPAP) for cooperative patient to avoid intubation
• Intubation (last resort): Indications - severe airway obstruction, refractory hypoxemia, impending respiratory arrest
• Ventilator strategy: Slow rates, prolonged expiratory phase, minimal PEEP (to avoid air trapping)
• Escalation to PICU

Red Flags Requiring Urgent Escalation

• SpO2 <90% despite oxygen
• Unable to speak
• Silent chest (no wheeze = no airflow)
• Cyanosis
• Altered consciousness
• Normalizing PaCO2 in a distressed child (sign of fatigue and impending arrest)

Key Teaching Point

Asthma Classification & Management: 3-4 Episodes/Month in a 7-Year-Old

Step 1: Classify Severity (Ages 5-11, NAEPP)

3-4 episodes/month = >2 days/week but not daily → Mild Persistent Asthma, Step 2

Step 2: Investigations to Confirm

1. Spirometry - FEV1, FVC, FEV1/FVC ratio; reversibility test (≥12% improvement after SABA = positive)
2. Peak Flow (PEFR) - baseline and variability (>20% diurnal variation supports asthma)
3. Chest X-ray - usually normal or shows hyperinflation; rules out alternative diagnoses
4. Allergy testing - skin prick test or serum specific IgE (identify triggers: dust mites, animal dander, pollen, mold)
5. CBC - eosinophilia supports atopic/allergic asthma
6. FeNO (Fractional exhaled Nitric Oxide) - elevated (>25 ppb) supports eosinophilic airway inflammation
7. Sweat chloride test - if cystic fibrosis is in the differential

Step 3: NAEPP Stepwise Management (Ages 5-11 years)

This boy = Step 2 (Mild Persistent)

Specific Step 2 Prescription for This Child:

• Controller (daily): Inhaled corticosteroid (ICS) - e.g., Fluticasone 100 mcg/day or Budesonide 200 mcg/day via MDI + spacer
• Reliever (PRN): Salbutamol (albuterol) SABA via MDI + spacer as needed
• SABA use >2 days/week for symptoms = signal to step up

Step 4: Non-Pharmacological Management (Every Step)

• Trigger identification and avoidance: Dust mites, pets, mold, cockroach, smoke, cold air, exercise
• Impermeable mattress/pillow covers (if dust mite sensitized, as part of multicomponent strategy)
• Allergen immunotherapy: Conditionally recommended (Steps 2-4) in children ≥5 years with controlled asthma and confirmed allergen sensitization
• Asthma Action Plan: Written plan for parents - what to do in green/yellow/red zones
• Inhaler technique education: Critical - poor technique is the most common cause of poor control
• Immunizations: Up to date including influenza and COVID-19

Step 5: Follow-Up & Step-Down

• Reassess in 2-6 weeks after starting controller therapy
• Step down if well controlled for ≥3 consecutive months
• Step up if not controlled (reassess adherence, technique, and triggers first)
• Refer to specialist if Step 3 or higher is required

GINA Symptom Control Quick Check (ask at every visit):

• Daytime symptoms >2 times/week? ✓
• Any night waking due to asthma?
• Reliever needed >2 times/week?
• Any activity limitation?